Breaking Finance News

Albemarle Corporation (NYSE:ALB) target bumped up to $121.00, released a ratings update earlier today by Zacks Investment Research

Only yesterday Albemarle Corporation (NYSE:ALB) traded -1.43% lower at $109.08. Albemarle Corporation’s 50-day average is $113.72 and its two hundred day average is $106.75. With the last close up 2.45% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.05% over the same time period. 2,138,074 shares of ALB traded, up from an avg. volume of 1,334,400

Zacks Investment Research raised the price target of Albemarle Corporation (NYSE:ALB) to $121.00 stating a potential upside of 0.11%.

On 06/29/2017, Needham Company LLC released a statement about Albemarle Corporation (NYSE:ALB) raised the target price from $0.00 to $36.00. At the time, this indicated a possible downside of -0.66%.

See Chart Below

Albemarle Corporation (NYSE:ALB)

Albemarle Corporation has a one year low of $75.11 and a one year high of $123.48 with a price-earnings ratio of 13.99 ALB’s total market value is currently $0.

In addition to Zacks Investment Research reporting its target price, a total of 15 firms have reported on the stock. The consensus target price is $69.00 with 3 firms rating the stock a strong buy, 6 firms rating the stock a buy, 8 firms rating the stock a hold, zero analysts rating the company a underperform, and lastly zero analysts rating the company a sell.

More About Albemarle Corporation (NYSE:ALB)

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.